Advertisement

Topics

MRSA (methicillin-resistant Staphylococcus aureus) Corporate

21:56 EDT 21st October 2018 | BioPortfolio

MicuRx Pharmaceuticals, Inc.

MicuRx is discovering and developing novel antibiotics to combat infections due to resistant bacteria. Positioned to capture the benefits of United States research and development expertise together with China's abundant scientific talent and cost-effective discovery, preclinical and development, the company has built a pipeline of drug candidates for the treatment of gram positive, gram negative ...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

Professor Ona's laboratory at Kyushu University

Started in beginning of 2002, Professor Ona's laboratory develops original theories, instruments and applications concerning human health, ES cell differentiation, aquaculture, environment and food security. The research achievements except above are as follows.1. Non-invasive prediction of next or final differentiation status of ES cell at the initiation ...

Akonni Biosystems, Inc.

Akonni Biosystems was founded in 2003 and has over 20 patents issued with 13 others pending. The Company’s core technology is based on work developed at Argonne National Laboratory and the Engelhardt Institute of Molecular Biology and utilizes gel-drop array technologies optimized for medical applications. Supported by a series of government grants and ...

American Bioanalytical Inc.

American Bioanalytical, Inc. (www.americanbio.com) founded in 1977, is a Natick, MA based company and a leading supplier of high quality biochemicals and reagent products for life science research and manufacturing applications. American Bioanalytical offers more than 350 biochemicals and reagents used in life science research applications. American Bioana...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

Nabi Biopharmaceuticals

NABI Biopharmaceuticals are a biopharmaceutical company focused on the development of products that address unmet medical needs in the areas of nicotine addiction and infectious disease. We leverage our experience and knowledge in powering the human immune system to target serious medical conditions in these areas. Our lead products in development are NicVAX® [ Nicotine Conjugate Vaccine ], an in...

Inhibitex

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. We currently have two product candidates in clinical development and four product candidates in preclinical development. Our product candidates have been developed based u...

GeneOhm Sciences, Inc

GeneOhm Sciences, Inc. is a molecular diagnostic company at the forefront of developing rapid, nucleic acid-based systems, to detect and identify infectious agents and genetic variations. Leveraging the advantages of rapid, molecular-based diagnostics, we aspire to transform health-care by enabling earlier and more definitive clinical decisions that improve both the quality and the cost of patient...

GeneOhm Sciences, Inc.

GeneOhm Sciences, Inc. is a molecular diagnostic company at the forefront of developing rapid, nucleic acid-based systems, to detect and identify infectious agents and genetic variations. Leveraging the advantages of rapid, molecular-based diagnostics, we aspire to transform health-care by enabling earlier and more definitive clinical decisions that improve both the quality and the cost of patient...

Destiny Pharma Ltd

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a completely different mode of action from conventional antibiotics. These compounds (codenamed XF Drugs) have been shown to work in such a way that minimizes the development of bacterial resistance to repea...

CUBICIN®

CUBICIN® (daptomycin for injection), the only once-a-day agent approved for the treatment of MRSA and MSSA in cSSSI, has been shown to be safe1 and effective2 against most Gram-positive organisms in cSSSI.Click here to view the progression of an actual case of left-ankle cellulitis successfully treated with CUBICIN therapy.Rapidly bactericidal in vitro,* CUBICIN is the first cyclic lipopeptide an...

Arpida Ltd

Arpida was founded in 1997 by Dr Dieter Gillessen, Prof. Bernhard Erni and Dr Ivan Kompis along with Dr André Lamotte from New Medical Technologies (NMT, now HBM BioVentures). Arpida’s mission is to discover, develop and commercialise innovative drugs and provide caregivers with novel therapies to overcome the growing problem of microbial resistance. Arpida uses an integrated multidisciplinary ...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

STOP MRSA Now Coalition

Grant Hill's MRSA Public Service Announcement:

Sorrento Therapeutics, Inc.

Sorrento Therapeutics has obtained an exclusive, worldwide license from The Scripps Research Institute (TSRI) to use this novel quorum sensing technology to identify fully human antibodies for the neutralization of Staph-specific signaling peptides that control bacterial virulence. A research group at the Institute has shown that sequestering these signaling peptides, which are integral components...

Molecular Detection Inc.

Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready(TM) molecular diagnostic tests for the detection of infectious diseases. The company's first product is a ready-to-use rapid detection hospital-based screening test for MRSA. These staph infection...

ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis a...

ImmuPharma PLC

ImmuPharma is a drug discovery and development group with its key operations in London and subsidiaries in Mulhouse, France and Basle, Switzerland. The Company aims to develop novel drugs to treat serious medical conditions for which there is a high unmet need. It has five drugs in development to treat 1) Lupus, 2) Cancer, 3) Severe Pain, 4) Highly resista...

Syntiron LLC

Syntiron is the recipient of a number of grants from the National Institutes of Health for the development of vaccines to prevent infections by Yersinia, Salmonella and Staphylococcus bacteria. In November 2008, Syntiron was awarded a $4 million contract from the US Defense Threat Reduction Agency (DTRA) for early stage development of vaccines against thre...

Aureus Pharma

Aureus Pharma, provides a range of scientific knowledge solutions enabling biopharmaceutical companies to better understand the relationships of biological targets to compounds under evaluation. Aureus experts continuously monitor and organize the most relevant information from the scientific literature, including experimental in vitro and in vivo protocol...

Kenta Biotech

Kenta Biotech is pioneering the research and development of fully human IgM antibodies that are desperately needed for the treatment of severe hospital-acquired infections. Antibodies generated from Kenta's proprietary MabIgX® technology effectively target bacteria independently of resistance to antimicrobial agents. Furthermore, the MabIgX® technolo...

TYRX, Inc.

TYRX, Inc. commercializes innovative, implantable combination drug/device products focused on infection control including the AIGISRx® Antibacterial Envelope and AIGISRx® FS products. AIGISRx products contain antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by organisms representing a majority of the infection...

Oculus Innovative Sciences, Inc.

Oculus Innovative Sciences is a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. The Microcyn Technology addresses the need for improved sol...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy MRSA (methicillin-resistant Staphylococcus aureus) market research data and corporate reports here